11/14/2024
8:00 PM | Pliant Therapeutics (Subject)
Redmile Group, LLC (Filed by)
| Form SC 13G | |
11/12/2024
10:53 AM | Laurion Capital Management LP (Filed by)
Pliant Therapeutics (Subject)
| Form SC 13G/A | |
10/04/2024
4:34 PM | Paradigm Biocapital Advisors LP (Filed by)
Pliant Therapeutics (Subject)
| Form SC 13G | |
09/27/2024
3:11 PM | Pliant Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2024
3:13 PM | Pliant Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/15/2024
10:54 AM | Pliant Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/12/2024
5:37 PM | Cummings Keith Lamont (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
07/12/2024
5:41 PM | Hull Hans (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2024
5:45 PM | Lefebvre Eric (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2024
5:15 PM | Ouimette Mike (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2024
5:22 PM | Coulie Bernard (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2024
4:01 PM | Lefebvre Eric (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2024
3:47 PM | Coulie Bernard (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2024
3:54 PM | Cummings Keith Lamont (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2024
3:41 PM | Ouimette Mike (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
7:15 PM | Curnutte John T (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
7:15 PM | Bruhn Suzanne Louise (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
7:15 PM | CROWELL GAYLE A (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
7:15 PM | Cline Darren S (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
7:15 PM | Pliant Therapeutics (Issuer)
Shah Smital (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
7:16 PM | Pliant Therapeutics (Issuer)
PYOTT DAVID E I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
7:16 PM | Huh Hoyoung (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
7:16 PM | Knobil Katharine (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
7:16 PM | MCCOURT Thomas A (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
6:57 PM | Krognes Steve E. (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
6:52 PM | Krognes Steve E. (Reporting)
Pliant Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/14/2024
6:43 AM | Pliant Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2024
3:27 PM | Pliant Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/06/2024
5:02 AM | Cummings Keith Lamont (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
6:45 AM | Pliant Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2024
3:20 PM | Pliant Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/14/2024
7:55 PM | Blue Owl Capital Holdings LP (Filed by)
Pliant Therapeutics (Subject)
| Form SC 13G | |
02/14/2024
4:10 PM | First Light Asset Management, LLC (Filed by)
Pliant Therapeutics (Subject)
| Form SC 13G | |
02/14/2024
7:52 AM | Deep Track Capital, LP (Filed by)
Pliant Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024
8:28 AM | FMR LLC (Filed by)
Pliant Therapeutics (Subject)
| Form SC 13G/A | |
02/08/2024
11:29 AM | Laurion Capital Management LP (Filed by)
Pliant Therapeutics (Subject)
| Form SC 13G | |
02/05/2024
6:31 AM | Pliant Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/25/2024
3:59 PM | BlackRock Inc. (Filed by)
Pliant Therapeutics (Subject)
| Form SC 13G | |
01/24/2024
3:56 PM | Coulie Bernard (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
4:18 PM | Lefebvre Eric (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
4:19 PM | Coulie Bernard (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
DeFi Coin on Verge of Breakout! (Ad) The blueprint for millionaires is here.
Don't let this be the missed opportunity you regret for years.
 Claim your FREE book now before it's too late! |
01/19/2024
4:19 PM | Hull Hans (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
4:19 PM | Cummings Keith Lamont (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
4:11 PM | Ouimette Mike (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
